Sign In
Buy MEIP
$3.07
+0 (+0%)
At Close: Dec 09, 2025
Do Options Traders Know Something About MEI Pharma (MEIP) Stock We Don't?
01:44pm, Wednesday, 01'st Dec 2021 Zacks Investment Research
Investors need to pay close attention to MEI Pharma (MEIP) stock based on the movements in the options market lately.
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
01:36pm, Wednesday, 01'st Dec 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir
The Food and Drug Adminis
Do Options Traders Know Something About MEI Pharma (MEIP) Stock We Don't?
09:59am, Wednesday, 01'st Dec 2021
Investors need to pay close attention to MEI Pharma (MEIP) stock based on the movements in the options market lately.
The B Cell Receptor Inhibitor Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts
MEI Pharma launches offering of 17.5M common shares
09:04pm, Tuesday, 30'th Nov 2021 Seeking Alpha
MEI Pharma Announces Proposed Public Offering of Common Stock
09:00pm, Tuesday, 30'th Nov 2021 Kwhen Finance
MEI Pharma Inc. (MEIP) Has Great Growth Outlook For 2021
05:00pm, Tuesday, 30'th Nov 2021 Marketing Sentinel
MEI Pharma Inc. (NASDAQ:MEIP) has a beta value of 1.44 and has seen 5.11 million shares traded in the recent trading session. The company, currently valued at $282.09M, closed the recent trade at $2.85 per share which meant it gained $0.4 on the day or 16.12% during that session. The MEIP stock price is -60.35% MEI Pharma Inc. (MEIP) Has Great Growth Outlook For 2021 Read More »
Best Penny Stocks To Buy Now? 3 To Watch Under $4
04:49pm, Tuesday, 30'th Nov 2021 PennyStocks
3 penny stocks to buy for under $5 but are they worth the risk?
The post Best Penny Stocks To Buy Now? 3 To Watch Under $4 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Hot Stocks: DLTR downgrade; JKS earnings; INTU, ARRY offerings; MEIP clinical data
01:31pm, Tuesday, 30'th Nov 2021 Seeking Alpha
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
01:12pm, Tuesday, 30'th Nov 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-Operative Administration
Cumber
Best Penny Stocks To Buy Now? 3 To Watch Under $4
11:49am, Tuesday, 30'th Nov 2021
3 penny stocks to buy for under $5 but are they worth the risk? The post Best Penny Stocks To Buy Now?
MEI Pharma (MEIP) Stock: Why The Price Surged Today
10:41am, Tuesday, 30'th Nov 2021
The stock price of MEI Pharma Inc (NASDAQ: MEIP) increased by over 17% during intraday trading. This is why it happened.
MEI Pharma, Kyowa Kirin Reveal Data From Zandelisib Trial In Follicular Lymphoma
10:09am, Tuesday, 30'th Nov 2021
MEI Pharma Inc (NASDAQ: MEIP) and Kyowa Kirin Co Ltd have announced data from the pivotal Phase 2 TIDAL study of zandelisib as a single agent for follicular lymphoma (FL) patients who received at
MEI Pharma, Inc. (NASDAQ:MEIP) Shares Acquired by State Street Corp
09:30am, Monday, 29'th Nov 2021 Transcript Daily
State Street Corp increased its holdings in MEI Pharma, Inc. (NASDAQ:MEIP) by 5.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,871,702 shares of the companys stock after buying an additional 101,586 shares during the period. State Street Corp owned about 1.66% of MEI Pharma worth []
MEI Pharma, Inc. (NASDAQ:MEIP) Expected to Post Quarterly Sales of $7.62 Million
07:10am, Monday, 22'nd Nov 2021 Dakota Financial News
Wall Street analysts expect MEI Pharma, Inc. (NASDAQ:MEIP) to post $7.62 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for MEI Pharmas earnings. The highest sales estimate is $13.40 million and the lowest is $2.20 million. MEI Pharma reported sales of $9.17 million during the []
